PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer

Molecular Medicine Reports

Volumn 5, Issue 5, 2012, Pages 1267-1270

  Kim, Mi Ja ^a   Kim, Su Kang ^a   Park, Hae Jeong ^a   Chung, Dae Han ^a   Park, Hyun Kyung ^a   Lee, Jong Seok ^a   Kwon, Kee Hwan ^a   Chung, Joo H ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Papillary thyroid cancer; Platelet derived growth factor receptor polypeptide; Platelet derived growth factor receptor polypeptide; Polymorphism

Indexed keywords

PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA; THYROID PAPILLARY CARCINOMA;

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RISK FACTORS; THYROID NEOPLASMS;

EID: 84863297452     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.784     Document Type: Article

References (18)

1. Sherman SI: Thyroid carcinoma. Lancet 361: 501-511, 2003.
2. Caron NR and Clark OH: Papillary thyroid cancer. Curr Treat Options Oncol 7: 309-319, 2006. (Pubitemid 44043660)
3. Sakorafas GH, Giotakis J and Stafyla V: Papillary thyroid microcarcinoma: a surgical perspective. Cancer Treat Rev 31: 423-438, 2005. (Pubitemid 41536166)
4. Fagin JA: Familial nonmedullary thyroid carcinoma - the case for genetic susceptibility. J Clin Endocrinol Metab 82: 342-344, 1997.
5. Goldgar DE, Easton DF and Cannon-Albright LA: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608, 1994. (Pubitemid 24336346)
6. Dai Y: Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature. Expert Opin Ther Pat 20: 885-897, 2010.
7. Appelmann I, Liersch R, Kessler T, Mesters RM and Berdel WE: Angiogenesis inhibition in cancer therapy: platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) and their receptors: biological functions and role in malignancy. Recent Results Cancer Res 180: 51-81, 2010.
8. Andrae J, Gallini R and Betsholtz C: Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312, 2008. (Pubitemid 351717519)
9. Chen KT, Lin JD, Liou MJ, Weng HF, Chang CA and Chan EC: An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines. Cancer Lett 231: 192-205, 2006. (Pubitemid 43038730)
10. Ozgen AG, Karadeniz M, Erdogan M, Berdeli A, Saygili F and Yilmaz C: The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients. J Endocrinol Invest 32: 491-494, 2009.
11. Lemos MC, Carrilho F, Rodrigues F, et al: Genetic polymorphism of CYP2D6 influences susceptibility to papillary thyroid cancer. Clin Endocrinol (Oxf) 67: 180-183, 2007. (Pubitemid 47076289)
12. Lin JC, Kuo WR, Chiang FY, et al: Glutathione peroxidase 3 gene polymorphisms and risk of differentiated thyroid cancer. Surgery 145: 508-513, 2009.
13. Barrett JC, Fry B, Maller J and Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265, 2005. (Pubitemid 40202029)
14. Jung KH, Ban JY, Kim HJ, et al: Genetic association study of THRB polymorphisms with obesity in Korean population. Mol Cell Toxicol 4: 124-131, 2008.
15. Gabriel SB, Schaffner SF, Nguyen H, et al: The structure of haplotype blocks in the human genome. Science 296: 2225-2229, 2002. (Pubitemid 34680308)
16. Wu LS, Tan CY, Wang LM, Lin CG and Wang JY: Variant in promoter region of platelet-derived growth factor receptor-alpha (PDGFR alpha) gene is associated with the severity and allergic status of childhood asthma. Int Arch Allergy Immunol 141: 37-46, 2006.
17. De Bustos C, Smits A, Strömberg B, Collins VP, Nistér M and Afink G: A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. J Med Genet 42: 31-37, 2005. (Pubitemid 40187118)
18. Kim HJ, Kim MH, Choe BK, et al: Genetic association between 5′-upstream single-nucleotide polymorphisms of PDGFRB and schizophrenia in a Korean population. Schizophr Res 103: 201-208, 2008.